2003
DOI: 10.1016/s0920-9964(02)00230-x
|View full text |Cite
|
Sign up to set email alerts
|

Comparative analysis of acute and chronic administration of haloperidol and clozapine using [3H] 2-deoxyglucose metabolic mapping

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
8
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 44 publications
2
8
0
Order By: Relevance
“…The effects of administration of clozapine and haloperidol were relatively small in contrast to the other findings reported here, remaining broadly in line with previous studies (Duncan et al, 1998a, Cochran et al, 2002, Wotanis et al, 2003. Clozapine and haloperidol also had minimal effect on mPFC-mVS coherence when administered alone.…”
Section: Discussionsupporting
confidence: 91%
“…The effects of administration of clozapine and haloperidol were relatively small in contrast to the other findings reported here, remaining broadly in line with previous studies (Duncan et al, 1998a, Cochran et al, 2002, Wotanis et al, 2003. Clozapine and haloperidol also had minimal effect on mPFC-mVS coherence when administered alone.…”
Section: Discussionsupporting
confidence: 91%
“…This has also been reported after acute administration of D2 but not D1 DA receptor antagonists [89], and after lesions of the nigrostriatal system [90] [91]. HAL also reportedly decreases 2-DG uptake in the raphe [92] [85] , and while this area does not express D2 receptors, it does receive more extensive glutamatergic innervation from the STN than previously thought [93]. HAL also reportedly decreases 2-DG uptake in the raphe [92] [85] , and while this area does not express D2 receptors, it does receive more extensive glutamatergic innervation from the STN than previously thought [93].…”
Section: -Deoxyglucose (2-dg) Uptakesupporting
confidence: 64%
“…Second, treatment with clozapine (which is not associated with acute EPS or chronic orofacial dyskinesias in animal models) was found to have a similar profile of 2-DG uptake in the GP and SN [84], M1 and GP [75] [85]. Second, treatment with clozapine (which is not associated with acute EPS or chronic orofacial dyskinesias in animal models) was found to have a similar profile of 2-DG uptake in the GP and SN [84], M1 and GP [75] [85].…”
Section: -Deoxyglucose (2-dg) Uptakementioning
confidence: 97%
See 1 more Smart Citation
“…Therefore, the allocation of subjects to each of these three groups was nonrandomized, but based on the medication prescribed by the in-charge clinician at the time of MRI scan. According to the existing literature on brain changes following administration of antipsychotics (Chakos et al, 1994;Cohen et al, 2003;Christensen et al, 2004;Grunder et al, 2003;Honey et al, 1999;Huang et al, 1999;Miller et al, 1997aMiller et al, , b, 2001Wotanis et al, 2003), the mean length of treatment of 8 weeks of our sample would be sufficient to observe brain changes in association with antipsychotic use.…”
Section: Pharmacological Treatmentmentioning
confidence: 97%